Jeffrey Alvis
Adolescent Medicine · McKinney, TXNPI 1124071667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $590, 2.2 times the $263 reported in 2019.
Across 112 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$415
- Pfizer$244
- Sanofi Pasteur Inc.$210
- Cranial Technologies, Inc$178
- Supernus Pharmaceuticals, Inc.$151
- Merck$97
- plus $773 from 17 others
What the payments were for
- Food & beverage$2,068100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 20 | $415 |
| Pfizer | 12 | $244 |
| Sanofi Pasteur Inc. | 10 | $210 |
| Cranial Technologies, Inc | 12 | $178 |
| Supernus Pharmaceuticals, Inc. | 10 | $151 |
| Merck | 5 | $97 |
| Sanofi-aventis U.S. LLC | 4 | $90 |
| Alk-abello, Inc | 4 | $89 |
| Seqirus USA Inc | 4 | $80 |
| Ironshore Pharmaceuticals Inc. | 5 | $75 |
| GSK | 5 | $70 |
| Cipher Pharmaceuticals US LLC | 1 | $60 |
| Verrica Pharmaceuticals Inc. | 3 | $51 |
| Genentech USA, Inc. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Phadia US Inc. | 2 | $36 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Tris Pharma Inc | 2 | $26 |
| Neos Therapeutics, LP | 1 | $17 |
| Novartis | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
How this compares
$2,068 in reported general payments places this provider in the 80th percentile of 68 adolescent medicine providers in Texas.
Other adolescent medicine in McKinney
- Joan PurcellThe Woodlands$87K
- Amy MiddlemanHouston$70K
- Augustine ElejeEl Paso$37K
- Richard RuppGalveston$20K
- Scott SpearEdinburg$11K
- Marcy BerryPlano$7K
- Marlo BrawnerLivingston$4K
- Dana Rubin-RemerDallas$4K
- Harish DhingraBedford$3K
- Surainder AjmaniHouston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.